1. Cellphire Therapeutics Closes $3,000,000 Funding Round

    Cellphire, Inc. announced today that it had closed a $3,000,000 funding round, with investments from both new investors and existing investors, management and the board of directors.  “The additional capital will augment the $69 million commitment from BARDA [the Biomedical Advanced Research and Development Authority],” said CEO Stephen Willard, “and enables us to initiate the […]